| GRANT | DATE | AMOUNT | PROGRAM |
|---|---|---|---|
|
American Camping Association, Inc.
ACA Professional Development 2024-2027 |
09.10.2024 | $180,809.00 | Type 1 Diabetes, Improve Outcomes |
|
The Regents of the University of Colorado, Denver
Epigenomic biomarkers of the incomplete maternal protection in type 1 diabetes |
09.10.2024 | $940,010.00 | Type 1 Diabetes, Prevent & Delay |
|
Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
GPPAD Coordination Center Continuation 2025-2029 |
08.27.2024 | $4,866,895.00 | Type 1 Diabetes, Prevent & Delay |
|
Benaroya Research Institute at Virginia Mason
Mechanisms of autoantibody reversion in at-risk subjects |
08.27.2024 | $1,078,203.00 | Type 1 Diabetes, Prevent & Delay |
|
Trustees of Indiana University
The Finding Immune Nascent Diabetes (FIND-T1D) |
08.13.2024 | $1,088,662.00 | Type 1 Diabetes, Prevent & Delay |
|
Université libre de Bruxelles
Studying the selective β cell sensitivity to a homozygous PD-L1 mutation in neonatal diabetes |
07.24.2024 | $430,517.00 | Type 1 Diabetes, Prevent & Delay |
|
Sanford World Clinics
Program DeteKtA: Detecting type 1 diabetes and preventing diabetic ketoacidosis (DKA) |
07.24.2024 | $317,880.00 | Type 1 Diabetes, Prevent & Delay |
|
Mass General Brigham for the Brigham and Women's Hospital
Accelerating progress and promoting quality T1D care for the poorest billion through the global PEN-Plus Partnership |
07.24.2024 | $23,998,776.00 | Type 1 Diabetes, Improve Outcomes |
|
Boston Medical Center Corporation
Supplemental funding for an effectiveness trial to support adoption of AID in underserved adults with T1D |
07.24.2024 | $900,100.00 | Type 1 Diabetes, Improve Outcomes |
|
Clinton Health Access Initiative Inc
REACH: Expanding access to primary care for diabetes and hypertension (2024-2027) |
07.09.2024 | $7,769,378.00 | Type 1 Diabetes, Improve Outcomes |
|
Washington University
Preclinical Development to advance a T1D antigen-specific immunotherapy called SAgA-T1D |
07.09.2024 | $2,591,258.00 | Type 1 Diabetes, Prevent & Delay |
|
The Regents of the University of Colorado, Denver
ASK the Experts 2024 |
07.09.2024 | $1,499,993.00 | Type 1 Diabetes, Prevent & Delay |
|
Duke University
Novel assays for proglucagon peptides to understand alpha cell function in health and diabetes |
07.09.2024 | $550,957.00 | Type 1 Diabetes, Prevent & Delay |
|
International Bank for Reconstruction and Development and International Development Association
Health System Transformation and Resilience Multi-Donor Trust Fund - Noncommunicable Disease Partnership: General Operating Support |
06.18.2024 | $5,000,000.00 | Type 1 Diabetes, Improve Outcomes |
|
Abvance Therapeutics, Inc.
Development of ABV100, a fixed-ratio coformulation of Insulin and Glucagon |
06.18.2024 | $3,920,820.00 | Type 1 Diabetes, Improve Outcomes |
|
The Regents of the University of Colorado, Denver
Defining human islet myeloid cell populations through progression of type 1 diabetes |
06.18.2024 | $757,077.00 | Type 1 Diabetes, Prevent & Delay |
|
Panorama Global
T1D Community Fund Stage II |
06.05.2024 | $4,450,000.00 | Type 1 Diabetes, Improve Outcomes |
|
Institut National de la Sante et de la Recherche Medicale
From Benign Islet Autoimmunity to Type 1 Diabetes: HLA-A- vs. HLA-B-restricted CD8+ T-Cell Biomarkers of Progression |
06.05.2024 | $827,337.00 | Type 1 Diabetes, Prevent & Delay |
|
Kyler Cares Foundation
Capacity Building Support |
05.15.2024 | $1,426,500.00 | Type 1 Diabetes, Improve Outcomes |
|
New Venture Fund
Type 1 Diabetes Camps Project (2025-2028) |
05.01.2024 | $6,001,184.00 | Type 1 Diabetes, Improve Outcomes |
|
Prev
12...45
Next
1 - 20 of 899 results
|
|||